mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.009 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.009 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
0.41 |
0.009 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.01 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.01 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.01 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.01 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.01 |